Facing declining valuations and funding challenges, public biotechs like bluebird bio are going private to restructure, ...

Unity Biotechnology (NASDAQ:UBX – Get Free Report)‘s stock had its “buy” rating reissued by Chardan Capital in a research ...

Analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Unity Biotechnology in a research report issued on Monday, March 10th. HC Wainwright analyst M. Caufield expects that the ...

Shortly after this publication, Bogdanove struck up a collaboration with Daniel Voytas, a plant geneticist at the University ...

Biotechnology has been in use by humans for over 10,000 years. Ancient bioscience incorporated processes like fermentation and cross breeding, while contemporary biotech could design an altogether new ...

The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.

LEXINGTON, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...

“The real stroke of brilliance is the notion that you make the cell younger, and then it would be more resilient to injury,” ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of ...

Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, offers his perspective on the state of CGTs, along with their potential for ...